calendar
11,426 catalysts · 10,843 approval · 5,000 device 510k · 4,728 grant · 3,086 8k filing · 2,000 device pma · 2,000 device recall
next 91 dayslessmore
MonWedFri
11,426 catalysts · 10,843 approval · 5,000 device 510k · 4,728 grant · 3,086 8k filing · 2,000 device pma · 2,000 device recall
no tagged catalysts yet
Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION
Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION
Sponsor: PF PRISM CV. Form: POWDER. Route: INTRAVENOUS
Sponsor: OTSUKA PHARM CO LTD. Form: FOR SUSPENSION, EXTENDED RELEASE. Route: INTRAMUSCULAR
Sponsor: PFIZER. Form: GEL. Route: TOPICAL
Sponsor: PFIZER. Form: SWAB. Route: TOPICAL
Sponsor: PFIZER. Form: LOTION. Route: TOPICAL
Sponsor: NOVARTIS. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: ABBVIE. Form: SUSPENSION. Route: ENTERAL
Sponsor: NOVO. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: ALKERMES. Form: FOR SUSPENSION, EXTENDED RELEASE. Route: INTRAMUSCULAR
Sponsor: SANDOZ. Form: SOLUTION/DROPS. Route: OPHTHALMIC
Sponsor: BAXTER HLTHCARE. Form: INJECTABLE. Route: INJECTION
Sponsor: PFIZER. Form: CAPSULE. Route: ORAL
Sponsor: ONESOURCE SPECIALTY. Form: INJECTABLE. Route: INJECTION
Sponsor: ONESOURCE SPECIALTY. Form: INJECTABLE. Route: INJECTION
Sponsor: MICRO LABS. Form: CAPSULE. Route: ORAL
Sponsor: BOEHRINGER INGELHEIM. Form: TABLET. Route: ORAL
Sponsor: LANNETT CO INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: LANNETT CO INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: LANNETT CO INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: LANNETT CO INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: LANNETT CO INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: LANNETT CO INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: LANNETT CO INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: LANNETT CO INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: LANNETT CO INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: LANNETT CO INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: LANNETT CO INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: LANNETT CO INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: LANNETT CO INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: LANNETT CO INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: LANNETT CO INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: BRACCO. Form: INJECTABLE. Route: INJECTION
Sponsor: BRISTOL MYERS SQUIBB. Form: INJECTABLE. Route: INJECTION
Sponsor: RADIUS. Form: TABLET, EFFERVESCENT. Route: ORAL
Sponsor: ACTAVIS ELIZABETH. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: BRECKENRIDGE. Form: TABLET. Route: ORAL
Sponsor: MYLAN. Form: TABLET. Route: ORAL-28
Sponsor: NEOS THERAPS. Form: TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE. Route: ORAL
Sponsor: ORION PHARMA. Form: TABLET. Route: ORAL
Sponsor: SUN PHARM. Form: TABLET. Route: SUBLINGUAL
Sponsor: UCB INC. Form: INJECTABLE. Route: INJECTION
Sponsor: SCIEGEN PHARMS. Form: TABLET. Route: ORAL
Sponsor: UPSHER SMITH LABS. Form: CAPSULE. Route: ORAL
Sponsor: TEVA PHARMS USA. Form: CAPSULE. Route: ORAL
Sponsor: SUN PHARM INDS INC. Form: CAPSULE. Route: ORAL
Sponsor: MYLAN PHARMS INC. Form: CAPSULE. Route: ORAL
Sponsor: TEVA PHARMS USA. Form: CAPSULE. Route: ORAL
Sponsor: DR REDDYS LABS LTD. Form: CAPSULE. Route: ORAL